To explore whether peptidoglycan fragments can be used as screening or diagnostic indicators for colorectal cancer
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
People who underwent total colonoscopy in gastroenteroscopy room.
People who agree to participate in this study and are willing to sign informed consent.
You may not be if
Previous diagnosis of malignant tumors other than colorectal cancer.
Received any of the following drug treatments within 1 month before sample collection: ① Drugs used for the treatment of colorectal diseases; ② Antibiotics; ③probiotics; ④ Laxatives.
Patients with a family history of colorectal cancer.
Clareo Health | A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer
